Peripheral plasma progesterone concentrations in intact and hysterectomized pseudopregnant rabbits decreased from Day 14. The rate of decrease in intact, but not in hysterectomized, rabbits accelerated on Day 17 and was associated with an increase in PGF-2 alpha levels in the uterine venous plasma. There was no change in uterine PGE-2 output during pseudopregnancy. In pregnant rabbits, peripheral plasma progesterone concentrations remained high up to Day 30, and there was no increase in uterine venous plasma levels of PGF-2 alpha on Day 17, PGF-2 alpha levels were elevated in uterine venous plasma on Day 25 of pregnancy, but there was no concurrent decline in plasma progesterone concentrations. Uterine venous plasma levels in PGE-2 increased markedly after Day 11 of pregnancy and reached very high concentrations in some rabbits.
Intrauterine instillation of oil, but not saline, induced both a decidual cell reaction and a marked elevation in the uterine PGF-alpha content of suitably sensitized ovariectomized mice. Uterine PGF-alpha concentrations were elevated within 5 min of the oil instillation, reached maximal levels within 30-60 min and then declined to near baseline levels again by 3 h. A similar increase in uterine PGF-alpha content in response to oil instillation was seen in non-sensitized females, although no decidual cell reaction developed. No significant changes in PGE or 6-oxo-PGF-1 content were observed. These results suggest that although the increase in uterine PGF-alpha content is not solely due to the distension of the uterus after intrauterine injection, the increase is not necessarily sufficient to induce a decidual cell reaction.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.